Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-12-16 Purchase |
2020-12-17 4:05 pm |
Lyra Therapeutics Inc. | LYRA | snyderman nancy lynn MD Director |
1,025 | $9.72 | $9,963 | 1,025 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-02-08 Option Award |
2021-02-10 4:05 pm |
N/A 2031-02-07 |
Lyra Therapeutics Inc. | LYRA | Richard Robert E. SVP of R&D |
18,000 | $0 | 18,000 (Direct) |
View |
2020-10-27 Option Award |
2020-10-29 8:45 pm |
N/A 2030-10-26 |
Lyra Therapeutics Inc. | LYRA | snyderman nancy lynn MD Director |
14,500 | $0 | 14,500 (Direct) |
View |
2020-08-03 Option Award |
2020-08-05 4:06 pm |
N/A 2030-08-03 |
Lyra Therapeutics Inc. | LYRA | Nelson Pamela E. Senior VP, Regulatory Affairs |
35,000 | $0 | 35,000 (Direct) |
View |
2020-06-24 Option Award |
2020-06-26 4:18 pm |
N/A 2030-06-24 |
Lyra Therapeutics Inc. | LYRA | Richard Robert E. SVP of R&D |
35,000 | $0 | 35,000 (Direct) |
View |